Tag Archive | "HPV-16"

HPV is changing the face of head and neck cancers

Friday, June 3, 2016

0 Comments

Source: www.healio.com Author: Christine Cona   A drastic increase in the number of HPV-associated oropharynx cancers, particularly those of the tonsil and base of tongue, has captured the attention of head and neck oncologists worldwide. In February, at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz., Maura Gillison, MD, PhD, professor and Jeg […]

Continue reading...

Nonsurgical surveillance safe, cost-effective for head, neck cancer

Thursday, March 24, 2016

0 Comments

Source: www.healio.com Author: Mehanna H, et al. Patients with head and neck cancer who underwent PET/CT–guided surveillance achieved similar survival outcomes as those who underwent planned neck dissections, according to the results of a prospective, randomized controlled trial. However, surveillance led to fewer surgical operations and complications and appeared more cost-effective than neck dissection, results […]

Continue reading...

Expanded age indication cleared for Gardasil 9 in males

Wednesday, December 30, 2015

0 Comments

Source: www.FormularyJournal.ModernMedicine.com Author: Erin Bastick   FDA approved an expanded age indication for Human Papillomavirus 9-valent Vaccine, Recombinant (Gardasil 9, Merck) in males. Seven HPV types in Gardasil 9 (HPV 16, 18, 31, 33, 45, 52, and 58) cause approximately 90% to 95% of HPV-related anal cancers, 90% of cervical cancers, and 80% of high-grade […]

Continue reading...

HPV DNA detected in mouthwash predicts oral cancer recurrence

Thursday, August 27, 2015

0 Comments

Source: www.onclive.com Author: Kelly Johnson The presence of HPV16 DNA is common at diagnosis of HPV-related oropharyngeal carcinoma (HPV-OPC) but rare after treatment. HPV-OPC has a favorable prognosis; however, 10% to 25% of patients experience disease progression, usually within 2 years of treatment. Patients who have HPV 16 DNA in their saliva following treatment of […]

Continue reading...

AstraZenica, Inovio strike deal to find HPV cancer vaccine

Monday, August 10, 2015

0 Comments

Source: www.philly.com Author: David Sell   Local drugmakers – big and small – struck a deal to try to develop a vaccine to prevent a form of cervical, head and neck cancer.  MedImmune, which is the biologics and research division with AstraZeneca, said Monday it will collaborate with Inovio Pharmaceuticals to develop an early stage […]

Continue reading...

Blood test could predict oral cancer recurrence

Saturday, August 2, 2014

0 Comments

Source: www.livescience.com Author: Rachael Rettner, Senior Writer A new blood and saliva test that looks for traces of the human papillomavirus (HPV) can predict whether some people with oral cancers will have their cancer come back, early research suggests. It helps to know as soon as possible that cancer has returned, because tumors that are […]

Continue reading...

Global trends suggest HPV positive oral cancer greatly increased in young males

Sunday, March 16, 2014

0 Comments

Source: www.zawya.com Author: staff While the incidence of smoking-related oral squamous cell carcinoma has decreased in many parts of the world, cases of human papilloma virus (HPV) positive oropharyngeal cancer (OPSCC) have greatly increased. Otolaryngologists are finding that the majority of their patients are male and a lot younger in age than their counterparts. This […]

Continue reading...

Study: A third of throat cancers linked to HPV infection

Monday, July 22, 2013

0 Comments

Source: www.upi.com Author: staff Human papillomavirus, the major cause of cervical cancer, also infects a third of throat cancer patients, U.S. and British researchers say. Aimee R. Kreimer of the National Cancer Institute, part of the National Institutes of Health, and Ruth C. Travis of University of Oxford, and numerous colleagues in several countries identified […]

Continue reading...

Enhanced radiation sensitivity in HPV-positive head and neck cancer

Monday, June 10, 2013

0 Comments

Source: http://cancerres.aacrjournals.org Authors:  Randall J. Kimple1,*,Molly A. Smith1,Grace C Blitzer1,Alexandra D Torres1,Joshua A Martin1,Robert Z. Yang1,Chimera R Peet1,Laurel D. Lorenz2,Kwangok P Nickel3,Aloysius J Klingelhutz4,Paul F Lambert5, andPaul M Harari1   Abstract Patients with human papillomavirus associated (HPV+) head and neck cancer (HNC) demonstrate significantly improved survival outcome compared to those with HPV-negative (HPV-) tumors. Published data […]

Continue reading...

Emergence of HPV 16 and sexually transmiitted oral cancer

Monday, April 1, 2013

0 Comments

Source: communities.washingtontimes.com Author: Dr. Ali by Ali Forghani The human papilloma virus (HPV) is the second leading cause of oral cancer. HPV is certainly not a newcomer to the disease world. It is one of the most common sexually transmitted disease on the planet. As of this writing, over 120 variations of the virus have […]

Continue reading...